27 results on '"Iriki H"'
Search Results
2. 052 Regulatory T cell-mediated, OX40-dependent peripheral tolerance to autoantigen, desmoglein 3
- Author
-
Iriki, H., primary, Takahashi, H., additional, Wada, N., additional, Hori, S., additional, and Amagai, M., additional
- Published
- 2019
- Full Text
- View/download PDF
3. 013 Cholesterol 25-hydroxylase expressing CD4+ T cell regulates skin inflammation
- Author
-
Takahashi, H., primary, Nomura, H., additional, Iriki, H., additional, Kubo, A., additional, Mukai, M., additional, Sasaki, T., additional, Mikami, Y., additional, O'Shea, J., additional, and Amagai, M., additional
- Published
- 2018
- Full Text
- View/download PDF
4. 425 Oxysterol function of lymphocyte cell death is differentially defined by types of cholesterol modification
- Author
-
Takahashi, H., primary, Nomura, H., additional, Iriki, H., additional, and Amagai, M., additional
- Published
- 2017
- Full Text
- View/download PDF
5. 292 Regulatory T cell is essential for deletion of autoreactive CD4+ T cells to desmoglein 3 in peripheral tolerance
- Author
-
Iriki, H., primary, Takahashi, H., additional, Wada, N., additional, and Amagai, M., additional
- Published
- 2017
- Full Text
- View/download PDF
6. 242 Novel immune regulation by CD4 + T cells via cholesterol 25-hydroxylase pathway
- Author
-
Takahashi, H., primary, Nomura, H., additional, Iriki, H., additional, Mikami, Y., additional, Kanno, Y., additional, Kubo, A., additional, O’Shea, J., additional, and Amagai, M., additional
- Published
- 2016
- Full Text
- View/download PDF
7. 292 Regulatory T cell is essential for deletion of autoreactive CD4+T cells to desmoglein 3 in peripheral tolerance
- Author
-
Iriki, H., Takahashi, H., Wada, N., and Amagai, M.
- Published
- 2017
- Full Text
- View/download PDF
8. 242 Novel immune regulation by CD4+T cells via cholesterol 25-hydroxylase pathway
- Author
-
Takahashi, H., Nomura, H., Iriki, H., Mikami, Y., Kanno, Y., Kubo, A., O’Shea, J., and Amagai, M.
- Published
- 2016
- Full Text
- View/download PDF
9. Sensory neurons promote immune homeostasis in the lung.
- Author
-
Tamari M, Del Bel KL, Ver Heul AM, Zamidar L, Orimo K, Hoshi M, Trier AM, Yano H, Yang TL, Biggs CM, Motomura K, Shibuya R, Yu CD, Xie Z, Iriki H, Wang Z, Auyeung K, Damle G, Demircioglu D, Gregory JK, Hasson D, Dai J, Chang RB, Morita H, Matsumoto K, Jain S, Van Dyken S, Milner JD, Bogunovic D, Hu H, Artis D, Turvey SE, and Kim BS
- Subjects
- Animals, Humans, Mice, Cytokines, Inflammation, Lymphocytes, Dermatitis, Atopic immunology, Immunity, Innate, Lung immunology, Sensory Receptor Cells enzymology
- Abstract
Cytokines employ downstream Janus kinases (JAKs) to promote chronic inflammatory diseases. JAK1-dependent type 2 cytokines drive allergic inflammation, and patients with JAK1 gain-of-function (GoF) variants develop atopic dermatitis (AD) and asthma. To explore tissue-specific functions, we inserted a human JAK1 GoF variant (JAK1
GoF ) into mice and observed the development of spontaneous AD-like skin disease but unexpected resistance to lung inflammation when JAK1GoF expression was restricted to the stroma. We identified a previously unrecognized role for JAK1 in vagal sensory neurons in suppressing airway inflammation. Additionally, expression of Calcb/CGRPβ was dependent on JAK1 in the vagus nerve, and CGRPβ suppressed group 2 innate lymphoid cell function and allergic airway inflammation. Our findings reveal evolutionarily conserved but distinct functions of JAK1 in sensory neurons across tissues. This biology raises the possibility that therapeutic JAK inhibitors may be further optimized for tissue-specific efficacy to enhance precision medicine in the future., Competing Interests: Declaration of interests B.S.K. is founder of KliRNA Biotech; he has served as a consultant for 23andMe, ABRAX Japan, AbbVie, Almirall, Amgen, Arcutis Biotherapeutics, Arena Pharmaceuticals, argenx, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Clexio Biosciences, Eli Lilly and Company, Escient Pharmaceuticals, Evommune, Galderma, Genentech, GlaxoSmithKline, Granular Therapeutics, Incyte Corporation, Innovaderm Research, Janssen, Kiniksa, LEO Pharma, Maruho, Novartis, Pfizer, Recens Medical, Regeneron Pharmaceuticals, Sanofi, Septerna, Triveni Bio, Vial, and WebMD; he has stock in ABRAX Japan, KliRNA Biotech, Locus Biosciences, and Recens Medical; he holds a patent for the use of JAK1 inhibitors for chronic pruritus; and he has a patent pending for the use of JAK inhibitors for interstitial cystitis. D.A. has contributed to scientific advisory boards at Pfizer, Takeda, FARE, and the KRF. D.B. is the founder of Lab11 Therapeutics.., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
10. Attenuation of OX40 signaling suppression by age disrupts peripheral deletion of CD4 + T cells specific for the epidermal autoantigen desmoglein 3.
- Author
-
Iriki H, Mukai M, Asahina Y, Kubo Y, Ito H, Amagai M, and Takahashi H
- Abstract
Various autoimmune responses increase with age, but the underlying mechanism is not clear. In this study, we used CD4
+ T cells expressing a transgenic T cell receptor specific for desmoglein 3 (Dsg3), which is the target antigen of the autoimmune bullous disease pemphigus vulgaris, to examine how peripheral immunological tolerance against pathogenic autoreactive CD4+ T cells changes with age. Dsg3-specific T cells were deleted within 14 days after adoptive transfer into young mice (8 weeks old), while they escaped deletion when transferred into older mice over 42 weeks old. Dsg3-specific T cells produced higher levels of the proinflammatory cytokine IFN-γ in aged mice than in young mice. In addition, the expression levels of both OX40 and Birc5, which are important for cell survival in T cell clonal proliferation, were higher in aged than in young mice. The dysfunction in suppressing proinflammatory cytokine secretion and Birc5 upregulation in Dsg3-specific autoreactive T cells may reflect an aspect of the preliminary steps in autoimmune disease development in the aged population. Understanding this mechanism may lead to better risk evaluation of autoimmune disease development and to onset prevention., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
11. Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases.
- Author
-
Iriki H, Takahashi H, and Amagai M
- Subjects
- Humans, Receptors, OX40, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, T-Lymphocytes immunology, Autoimmune Diseases, Dermatitis, Atopic
- Abstract
OX40 is an important costimulatory molecule for T-cell expansion and survival. Because OX40 is expressed on most T-cell subsets, it is an attractive therapeutic target for a variety of T-cell‒mediated diseases. Clinical trials are already underway for some skin inflammatory diseases. In this review, we present various observations that improve our understanding of how OX40-targeted therapy can be applied for skin inflammatory diseases, such as atopic dermatitis and psoriasis, T helper (Th)2- and Th17-mediated diseases, respectively. The important OX40/OX40L-mediated interaction between T cells and other immune cells is also discussed in terms of skin autoimmune diseases, such as alopecia areata and pemphigus. Regulatory T cells (Tregs) highly express OX40, and the skin harbors a large Treg population; thus, understanding how OX40-targeted treatment acts on Tregs is vital for the development of therapeutic strategies for various skin diseases., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
12. T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen.
- Author
-
Takahashi H, Iriki H, and Asahina Y
- Subjects
- Animals, Humans, Mice, Autoantibodies, Autoantigens, Autoimmunity, Desmoglein 1, Desmoglein 3, Pemphigus pathology, T-Lymphocytes immunology
- Abstract
Pemphigus is a life-threatening autoimmune bullous disease mediated by anti-desmoglein IgG autoantibodies. Pemphigus is mainly classified into three subtypes: pemphigus vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus. The pathogenicity of autoantibodies has been extensively studied. Anti-human CD20 antibody therapy targeting B cells emerged as a more effective treatment option compared to conventional therapy for patients with an intractable disease. On the other hand, autoreactive T cells are considered to be involved in the pathogenesis based on the test results of human leukocyte antigen association, autoreactive T cell detection, and cytokine profile analysis. Research on the role of T cells in pemphigus has continued to progress, including that on T follicular helper cells, which initiate molecular mechanisms involved in antibody production in B cells. Autoreactive T cell research in mice has highlighted the crucial roles of cellular autoimmunity and improved the understanding of its pathogenesis, especially in paraneoplastic pemphigus. The mouse research has helped elucidate novel regulatory mechanisms of autoreactive T cells, such as thymic tolerance to desmoglein 3 and the essential roles of regulatory T cells, Langerhans cells, and other molecules in peripheral tissues. This review focuses on the immunological aspects of autoreactive T cells in pemphigus by providing detailed information on various related topics., (© 2022 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.)
- Published
- 2023
- Full Text
- View/download PDF
13. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
- Author
-
Takamiyagi S, Iriki H, Asahina Y, Furuichi Y, Funakoshi T, Ichikawa M, Mikami Y, Okita H, Sakiyama T, Inazumi T, Amagai M, and Takahashi H
- Subjects
- Aged, Cytomegalovirus, Humans, Male, Cytomegalovirus Infections complications, Cytomegalovirus Infections diagnosis, Drug Hypersensitivity, Drug Hypersensitivity Syndrome complications, Drug Hypersensitivity Syndrome etiology, Enterocolitis chemically induced, Enterocolitis diagnosis, Eosinophilia chemically induced, Eosinophilia complications, Graft vs Host Disease complications, Graft vs Host Disease drug therapy
- Abstract
Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug adverse reaction with skin eruption and visceral organ involvement. The characteristic clinical features of DIHS/DRESS are reactivation of human herpesviruses (HHV) and the development of autoimmune diseases, but their pathogenesis and associations are not yet understood. Here, we report a 66-year-old man who presented with fever, generalized erythema, diffuse lymphadenopathy, and diarrhea after 3 weeks of treatment with zonisamide. Reactivation of HHV-6 and cytomegalovirus (CMV) was detected during the clinical course. The patient was diagnosed with DIHS/DRESS and treated with systemic prednisolone, i.v. immunoglobulin therapy, and ganciclovir. However, severe enterocolitis persisted for 6 months. A series of examinations revealed features of both CMV enterocolitis, as indicated by identification of a few CMV-positive cells on immunohistochemical analysis, and graft-versus-host disease (GVHD)-like enterocolitis indicated by orange-peel appearance on endoscopic examination and histopathological loss of goblet cells. Intractable enterocolitis continued and the patient finally died of pneumonia. An autoimmune predisposition in DIHS/DRESS patients in combination with CMV reactivation was considered to trigger the severe enterocolitis of this case that showed GVHD-like features of the gastrointestinal tract. GVHD-like organ damage is a pathological condition rarely observed in DIHS/DRESS but should be recognized as one of the most severe complications of the disease., (© 2022 Japanese Dermatological Association.)
- Published
- 2022
- Full Text
- View/download PDF
14. Superimposition of checkerboard distribution of ephelides and neurofibromas in a patient with segmental neurofibromatosis.
- Author
-
Iriki H, Umegaki-Arao N, Kakuta R, Fujita H, Aoki S, Amagai M, Sasaki T, Hamamoto Y, Nakayama R, and Kubo A
- Abstract
Competing Interests: None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
15. IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse.
- Author
-
Nomura H, Wada N, Takahashi H, Kase Y, Yamagami J, Egami S, Iriki H, Mukai M, Kamata A, Ito H, Fujii H, Ishikura T, Koseki H, Watanabe T, Yamada T, Ohara O, Koyasu S, and Amagai M
- Subjects
- Adult, Aged, Animals, Autoimmunity immunology, B-Lymphocytes immunology, Desmoglein 3 immunology, Female, Gene Knock-In Techniques, Humans, Immunoglobulin G genetics, Immunoglobulin M genetics, Keratinocytes metabolism, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Pemphigus immunology, Pemphigus pathology, Receptors, IgG metabolism, Desmoglein 3 genetics, Immunoglobulin Class Switching immunology, Immunoglobulin G immunology, Immunoglobulin M immunology, Pemphigus genetics, Receptors, IgG genetics
- Abstract
Pemphigus vulgaris is an autoimmune blistering disease caused by IgG targeting desmoglein 3 (Dsg3), an adhesion molecule of keratinocytes. Anti-Dsg3 IgG production is prevented in healthy individuals, but it is unclear how Dsg3-specific B cells are regulated. To clarify the immunological condition regulating Dsg3-specific B cells, a pathogenic anti-Dsg3 Ig (AK23) knock-in mouse was generated. AK23 knock-in B cells developed normally without undergoing deletion or acquiring an anergic phenotype in vivo. The knock-in B cells showed Ca
2+ influx upon IgM cross-linking and differentiated into AK23-IgG+ B cells after LPS and IL-4 stimulation in vitro that induced a pemphigus phenotype after adoptive transfer into Rag2-/- mice. However, the knock-in mouse itself produced AK23-IgM but little IgG without blisters in vivo. Dsg3 immunization and skin inflammation caused AK23-IgG production and a pemphigus phenotype in vivo. Furthermore, Fcgr2b deficiency or haploinsufficiency spontaneously induced AK23-IgG production and a pemphigus phenotype with poor survival rates in AK23 knock-in mice. To assess Fcgr2b involvement in Ig class-switch efficiency, postswitch transcripts of B cells were quantified and significantly higher in Fcgr2b-/- and Fcgr2b+/- mice than wild-type mice in a gene dose-dependent manner. Finally, RNA sequencing revealed reduced expression of FCGR2B and FcγRIIB-related genes in patient B cells. These results indicated that Dsg3-specific B cells do not spontaneously perform pathogenic class switching in vivo, and pemphigus phenotype induction was prevented under normal conditions. Attenuated FcγRIIB signaling is also one of the drivers for pathogenic class switching and is consistent with immunological features identified from clinical samples. This study unveiled a characteristic immune state silencing autoreactive B cells in mice., (Copyright © 2022 by The American Association of Immunologists, Inc.)- Published
- 2022
- Full Text
- View/download PDF
16. Diagnostic utility of the basophil activation test in natto-induced hypersensitivity.
- Author
-
Fukuda R, Ouchi T, Asahina Y, Shiiya C, Takeuchi S, Yasuda-Sekiguchi F, Iriki H, Kouno M, Takahashi S, Tanikawa A, Amagai M, and Takahashi H
- Subjects
- Case-Control Studies, Female, Humans, Male, Phosphoric Diester Hydrolases blood, Pyrophosphatases blood, Soy Foods adverse effects, Urticaria complications, Basophil Degranulation Test methods, Food Hypersensitivity diagnosis
- Abstract
Background: Natto (fermented soybeans)-induced hypersensitivity is characterized by delayed symptom onset that hampers diagnosis. We aimed to clarify the clinical utility of the basophil activation test (BAT) in the diagnosis of natto-induced hypersensitivity., Methods: Five patients with a history of anaphylaxis and chronic urticaria suspected of natto-induced hypersensitivity and seven with chronic spontaneous urticaria clinically unrelated to natto were enrolled in the patient and control groups, respectively. The BAT was performed with two incubation times, 15 min and 1 h, in combination with various concentrations of natto-mucilage extract., Results: In controls, CD203c levels in basophils remained low in the 15-min incubation but were significantly increased in the 1-h incubation. In the patient group, in the 15-min condition, basophil CD203c was significantly upregulated by natto mucilage but not by soybean vs controls (P = 0.001). Low concentrations of natto mucilage were sufficient to upregulate basophil CD203c in the anaphylaxis cases, but high concentrations were required to induce the same effect in the urticaria cases. Finally, the dose-dependent pattern of the BAT results differed significantly between the anaphylaxis and urticaria cases (P = 0.006). Thus, a strong background reaction was observed in the BAT with 1 h incubation; 15 min of incubation was sufficient to identify patients with natto-induced hypersensitivity and may distinguish the clinical phenotype of natto-induced hypersensitivity, i.e., anaphylaxis or urticaria., Conclusions: The BAT with a 15-min incubation period is useful in diagnosing natto-induced hypersensitivity., (Copyright © 2021 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus.
- Author
-
Iriki H, Takahashi H, Wada N, Nomura H, Mukai M, Kamata A, Ito H, Yamagami J, Matsui T, Kurebayashi Y, Mise-Omata S, Nishimasu H, Nureki O, Yoshimura A, Hori S, and Amagai M
- Subjects
- Abatacept pharmacology, Adoptive Transfer, Animals, Coculture Techniques, DNA-Binding Proteins genetics, Desmoglein 3 genetics, Estrogen Antagonists pharmacology, Female, Gene Expression Regulation drug effects, Gene Expression Regulation immunology, Immune Checkpoint Inhibitors pharmacology, Male, Mice, Mice, Knockout, T-Lymphocytes, Regulatory, Tamoxifen pharmacology, DNA-Binding Proteins metabolism, Desmoglein 3 metabolism, Pemphigus immunology
- Abstract
Antigen-specific peripheral tolerance is crucial to prevent the development of organ-specific autoimmunity. However, its function decoupled from thymic tolerance remains unclear. We used desmoglein 3 (Dsg3), a pemphigus antigen expressed in keratinocytes, to analyze peripheral tolerance under physiological antigen-expression conditions. Dsg3-deficient thymi were transplanted into athymic mice to create a unique condition in which Dsg3 was expressed only in peripheral tissue but not in the thymus. When bone marrow transfer was conducted from high-avidity Dsg3-specific T cell receptor-transgenic mice to thymus-transplanted mice, Dsg3-specific CD4
+ T cells developed in the transplanted thymus but subsequently disappeared in the periphery. Additionally, when Dsg3-specific T cells developed in Dsg3-/- mice were adoptively transferred into Dsg3-sufficient recipients, the T cells disappeared in an antigen-specific manner without inducing autoimmune dermatitis. However, Dsg3-specific T cells overcame this disappearance and thus induced autoimmune dermatitis in Treg-ablated recipients but not in Foxp3 -mutant recipients with dysfunctional Tregs. The molecules involved in disappearance were sought by screening the transcriptomes of wild-type and Foxp3 -mutant Tregs. OX40 of Tregs was suggested to be responsible. Consistently, when OX40 expression of Tregs was constrained, Dsg3-specific T cells did not disappear. Furthermore, Tregs obtained OX40L from dendritic cells in an OX40 -dependent manner in vitro and then suppressed OX40L expression in dendritic cells and Birc5 expression in Dsg3-specific T cells in vivo. Lastly, CRISPR/Cas9-mediated knockout of OX40 signaling in Dsg3-specific T cells restored their disappearance in Treg-ablated recipients. Thus, Treg-mediated peripheral deletion of autoreactive T cells operates as an OX40 -dependent regulatory mechanism to avoid undesired autoimmunity besides thymic tolerance., Competing Interests: The authors declare no competing interest.- Published
- 2021
- Full Text
- View/download PDF
18. CRISPR Toolbox for Genome Editing in Dictyostelium .
- Author
-
Yamashita K, Iriki H, Kamimura Y, and Muramoto T
- Abstract
The development of new techniques to create gene knockouts and knock-ins is essential for successful investigation of gene functions and elucidation of the causes of diseases and their associated fundamental cellular processes. In the biomedical model organism Dictyostelium discoideum , the methodology for gene targeting with homologous recombination to generate mutants is well-established. Recently, we have applied CRISPR/Cas9-mediated approaches in Dictyostelium , allowing the rapid generation of mutants by transiently expressing sgRNA and Cas9 using an all-in-one vector. CRISPR/Cas9 techniques not only provide an alternative to homologous recombination-based gene knockouts but also enable the creation of mutants that were technically unfeasible previously. Herein, we provide a detailed protocol for the CRISPR/Cas9-based method in Dictyostelium . We also describe new tools, including double knockouts using a single CRISPR vector, drug-inducible knockouts, and gene knockdown using CRISPR interference (CRISPRi). We demonstrate the use of these tools for some candidate genes. Our data indicate that more suitable mutants can be rapidly generated using CRISPR/Cas9-based techniques to study gene function in Dictyostelium ., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Yamashita, Iriki, Kamimura and Muramoto.)
- Published
- 2021
- Full Text
- View/download PDF
19. Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum.
- Author
-
Asano Y, Yamashita K, Hasegawa A, Ogasawara T, Iriki H, and Muramoto T
- Subjects
- CRISPR-Associated Protein 9 genetics, CRISPR-Cas Systems, Dictyostelium genetics, Gene Editing, CRISPR-Associated Protein 9 metabolism, Dictyostelium metabolism, Nucleotides metabolism
- Abstract
The powerful genome editing tool Streptococcus pyogenes Cas9 (SpCas9) requires the trinucleotide NGG as a protospacer adjacent motif (PAM). The PAM requirement is limitation for precise genome editing such as single amino-acid substitutions and knock-ins at specific genomic loci since it occurs in narrow editing window. Recently, SpCas9 variants (i.e., xCas9 3.7, SpCas9-NG, and SpRY) were developed that recognise the NG dinucleotide or almost any other PAM sequences in human cell lines. In this study, we evaluated these variants in Dictyostelium discoideum. In the context of targeted mutagenesis at an NG PAM site, we found that SpCas9-NG and SpRY were more efficient than xCas9 3.7. In the context of NA, NT, NG, and NC PAM sites, the editing efficiency of SpRY was approximately 60% at NR (R = A and G) but less than 22% at NY (Y = T and C). We successfully used SpRY to generate knock-ins at specific gene loci using donor DNA flanked by 60 bp homology arms. In addition, we achieved point mutations with efficiencies as high as 97.7%. This work provides tools that will significantly expand the gene loci that can be targeted for knock-out, knock-in, and precise point mutation in D. discoideum.
- Published
- 2021
- Full Text
- View/download PDF
20. Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4 + T cells to desmoglein 3.
- Author
-
Iriki H, Mukai M, Ito H, Kurebayashi Y, Amagai M, and Takahashi H
- Subjects
- Animals, Desmoglein 3 genetics, Disease Models, Animal, Humans, Imiquimod administration & dosage, Imiquimod immunology, Mice, Mice, Knockout, Pemphigus immunology, Skin drug effects, Skin immunology, Thymus Gland cytology, CD4-Positive T-Lymphocytes immunology, Dermatitis, Allergic Contact immunology, Desmoglein 3 immunology, Immune Tolerance, Thymus Gland immunology
- Abstract
Background: The thymus plays an essential role in removing autoreactive T cells. Autoantigen-expressing thymic epithelial cells (TECs) contribute to the tolerogenic process. The thymus transiently shrinks as an acute thymic involution (ATI) under various inflammatory conditions. However, whether ATI occurs during local skin inflammation remains unclear, as does its influence on thymic immune tolerance., Objective: We investigated whether imiquimod-induced dermatitis causes ATI and impairs thymic immune tolerance against desmoglein 3 (Dsg3), an epidermal autoantigen of pemphigus vulgaris., Methods: 5% imiquimod cream was applied daily, at 62.5 mg/day (high dose group) or 31.25 mg/day (low dose group), for 1 week on the back of wild-type mice, and to wild-type mice that had undergone bone-marrow transplantation from Dsg3-specific T-cell receptor (TCR) transgenic-Rag2
-/- mice. Next, thymocytes, TECs and other immune cells were analyzed by flow cytometry. TEC-associated Dsg3 expression was also analyzed by immunofluorescence staining., Results: Thymus weight and thymocyte number in all developmental stages decreased in a dose-dependent manner under imiquimod-induced dermatitis. The number of total TECs, specifically medullary, but not cortical, TECs, decreased in high and low dose groups. Accordingly, the number of Dsg3-experssing UEA-1+ keratin 5+ mTEC decreased in the thymus during imiquimod-induced dermatitis. Although Dsg3-sepcific transgenic thymocytes was usually deleted in the thymus under physiological condition by central tolerance, Dsg3-sepcific transgenic CD4+ CD8- thymocytes significantly increased in number under imiquimod-induced dermatitis., Conclusion: These findings indicate a crosstalk between skin and thymus in adult mice and suggest that skin inflammation may impair thymic tolerance to autoantigens, such as Dsg3., Competing Interests: Declaration of Competing Interest The authors report no declarations of interest., (Copyright © 2020 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
21. Case of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid that developed after a scabies infestation.
- Author
-
Iriki H, Adachi T, Matsuda H, Chinen K, Arakawa H, Yamagami J, Nishie W, and Yokouchi M
- Subjects
- Humans, Hypoglycemic Agents, Dipeptidyl-Peptidase IV Inhibitors adverse effects, Pemphigoid, Bullous chemically induced, Pemphigoid, Bullous diagnosis, Scabies complications, Scabies diagnosis, Scabies drug therapy
- Published
- 2020
- Full Text
- View/download PDF
22. Generation of deletions and precise point mutations in Dictyostelium discoideum using the CRISPR nickase.
- Author
-
Iriki H, Kawata T, and Muramoto T
- Subjects
- Base Sequence, Deoxyribonuclease I genetics, Deoxyribonuclease I metabolism, Gene Editing methods, Point Mutation, RNA, Guide, CRISPR-Cas Systems genetics, RNA, Guide, CRISPR-Cas Systems metabolism, CRISPR-Cas Systems genetics, Dictyostelium genetics
- Abstract
The CRISPR/Cas9 system enables targeted genome modifications across a range of eukaryotes. Although we have reported that transient introduction of all-in-one vectors that express both Cas9 and sgRNAs can efficiently induce multiple gene knockouts in Dictyostelium discoideum, concerns remain about off-target effects and false-positive amplification during mutation detection via PCR. To minimise these effects, we modified the system to permit gene deletions of greater than 1 kb via use of paired sgRNAs and Cas9 nickase. An all-in-one vector expressing the Cas9 nickase and sgRNAs was transiently introduced into D. discoideum, and the resulting mutants showed long deletions with a relatively high efficiency of 10-30%. By further improving the vector, a new dual sgRNA expression vector was also constructed to allow simultaneous insertion of two sgRNAs via one-step cloning. By applying this system, precise point mutations and genomic deletions were generated in the target locus via simultaneous introduction of the vector and a single-stranded oligonucleotide template without integrating a drug resistance cassette. These systems enable simple and straightforward genome editing that requires high specificity, and they can serve as an alternative to the conventional homologous recombination-based gene disruption method in D. discoideum., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
23. Autoimmunity and immunological tolerance in autoimmune bullous diseases.
- Author
-
Takahashi H, Iriki H, Mukai M, Kamata A, Nomura H, Yamagami J, and Amagai M
- Subjects
- Animals, Humans, Autoimmunity immunology, Immune Tolerance immunology, Pemphigus classification, Pemphigus immunology
- Abstract
Autoimmune diseases are devastating conditions in which the immune system is directed against the host, leading to life-threatening destruction of organs. Although autoantigens are ill-defined in most autoimmune diseases, this is not the case in the skin. Autoimmune bullous diseases have been extensively studied with detailed characterization of autoantigens, the epitopes that are targeted, and the mechanisms of action that mediate autoimmune tissue destruction. Pemphigus is an autoimmune bullous disease caused by circulating IgG that targets two desmosomal proteins, desmoglein 1 and 3, which are crucial for cell-cell adhesion of keratinocytes. Binding of auto-antibodies to desmogleins impairs keratinocyte adhesion, leading to severe blistering disease. Mouse models that recapitulate the human disease have been instrumental in elucidating the detailed pathophysiology. Taking advantage of the fact that desmogleins are specifically targeted in pemphigus, studying humoral and cellular autoimmunity against these autoantigens provides us with an opportunity to understand not only the effector mechanisms of B and T cells in mediating pathology but also how autoreactive lymphocytes are regulated during development in the thymus and post-development in the periphery. This review introduces pemphigus and its subtypes as prototypic autoimmune diseases from which recent basic and translational developments should provide insight into how autoimmunity develops., (© The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
24. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Dictyostelium .
- Author
-
Muramoto T, Iriki H, Watanabe J, and Kawata T
- Subjects
- Homologous Recombination, CRISPR-Associated Protein 9 genetics, CRISPR-Cas Systems, Dictyostelium genetics, Gene Editing trends, Genetic Vectors genetics
- Abstract
In the last 30 years, knockout of target genes via homologous recombination has been widely performed to clarify the physiological functions of proteins in Dictyostelium . As of late, CRISPR/Cas9-mediated genome editing has become a versatile tool in various organisms, including Dictyostelium , enabling rapid high-fidelity modification of endogenous genes. Here we reviewed recent progress in genome editing in Dictyostelium and summarised useful CRISPR vectors that express sgRNA and Cas9, including several microorganisms. Using these vectors, precise genome modifications can be achieved within 2⁻3 weeks, beginning with the design of the target sequence. Finally, we discussed future perspectives on the use of CRISPR/Cas9-mediated genome editing in Dictyostelium .
- Published
- 2019
- Full Text
- View/download PDF
25. Case of lamotrigine-induced drug adverse reaction under tocilizumab treatment with clinical and virological features of drug-induced hypersensitivity syndrome.
- Author
-
Iriki H, Ouchi T, Ito H, Sawada M, Mukai M, Nomura H, Baba Y, Adachi T, Funakoshi T, Amagai M, and Takahashi H
- Subjects
- Adult, Antibodies, Monoclonal, Humanized therapeutic use, Biopsy, C-Reactive Protein analysis, DNA, Viral isolation & purification, Drug Hypersensitivity Syndrome blood, Drug Hypersensitivity Syndrome drug therapy, Drug Hypersensitivity Syndrome etiology, Exanthema chemically induced, Exanthema diagnosis, Exanthema drug therapy, Exanthema pathology, Female, Fever blood, Fever chemically induced, Fever diagnosis, Fever drug therapy, Herpesviridae genetics, Herpesviridae isolation & purification, Humans, Interleukin-6 antagonists & inhibitors, Lamotrigine, Prednisone therapeutic use, Recurrence, Skin drug effects, Skin pathology, Anticonvulsants adverse effects, Arthritis, Rheumatoid drug therapy, Drug Hypersensitivity Syndrome diagnosis, Epilepsy drug therapy, Triazines adverse effects
- Abstract
The pathological mechanisms and immunological kinetics of drug-induced hypersensitivity syndrome (DIHS), including the relevance of interleukin (IL)-6, remain unclear. We report a case of drug adverse reaction that does not fulfill the diagnostic criteria of DIHS but mimics its characteristic features. Because the patient was under anti-IL-6 therapy at the onset, some symptoms typically seen in DIHS were absent, such as fever and leukocyte count abnormalities. However, the characteristic features of DIHS were clearly observed in the subsequent course, including the repeated recurrence of skin rash, prolonged liver dysfunction and reactivation of herpes viruses. This case suggested that IL-6 role at the onset is not a main factor to determine the subsequent pathomechanism of DIHS and attention should be paid to the preceding therapy for achieving accurate diagnosis., (© 2018 Japanese Dermatological Association.)
- Published
- 2018
- Full Text
- View/download PDF
26. Marked decrease in serum squamous cell carcinoma antigen level after antitumor necrosis factor alpha therapy in six cases of severe psoriasis.
- Author
-
Iriki H, Tanese K, Furuichi Y, Takeshita K, and Saito M
- Subjects
- Adult, Aged, Biomarkers blood, Female, Humans, Male, Middle Aged, Severity of Illness Index, Tumor Necrosis Factor-alpha antagonists & inhibitors, Adalimumab therapeutic use, Antigens, Neoplasm blood, Dermatologic Agents therapeutic use, Infliximab therapeutic use, Psoriasis blood, Psoriasis drug therapy, Serpins blood
- Published
- 2016
- Full Text
- View/download PDF
27. Toxic epidermal necrolysis in the absence of circulating T cells: a possible role for resident memory T cells.
- Author
-
Iriki H, Adachi T, Mori M, Tanese K, Funakoshi T, Karigane D, Shimizu T, Okamoto S, and Nagao K
- Subjects
- Antigens, CD analysis, Antigens, Differentiation, T-Lymphocyte analysis, Cerebral Hemorrhage complications, Fatal Outcome, Humans, Immunologic Memory, Lectins, C-Type analysis, Leukocyte Common Antigens analysis, Male, Middle Aged, Stevens-Johnson Syndrome complications, Stevens-Johnson Syndrome drug therapy, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Stevens-Johnson Syndrome immunology
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.